The history of compulsive sexual behavior within American diagnostic classification is a history of successive deferrals, each reflecting genuine methodological concern and the contested cultural politics of sexual behavior. DSM-III-R (1987) subsumed excessive sexual behavior within the residual category of “Sexual Disorder Not Otherwise Specified” — acknowledging clinical presentations without establishing formal criteria. DSM-IV removed explicit mention of sexual addiction and hypersexuality, citing insufficient empirical validation. The practical consequence was that clinicians working with patients clearly harmed by compulsive sexual behavior had no recognized diagnostic framework within which to conceptualize and communicate their work.
The DSM-5 revision process represented the most systematic effort to evaluate the construct on its merits. The Sexual and Gender Identity Disorders Working Group reviewed a formally proposed diagnosis of “Hypersexual Disorder,” which incorporated distress, functional impairment, unsuccessful cessation attempts, the use of sexual behavior as a mood-regulation strategy, and harm continuation as diagnostic criteria. Notably, the proposal did not require tolerance or withdrawal — explicitly rejecting the addiction model’s dependence construct as a necessary diagnostic anchor.
This was conceptually important: it indicated that thoughtful clinicians had recognized, years before ICD-11 formalization, that behavioral dyscontrol and functional harm — not the neurobiological features of addiction — were the clinically defensible diagnostic core.
Hypersexual Disorder was excluded from DSM-5 in 2013 on grounds that the research base was insufficient to meet the DSM’s methodological standards for new diagnostic entities. The exclusion was not a scientific judgment that the phenomenon failed to exist; it was a methodological judgment about whether the evidence base was adequate to formalize it. The practical consequences for U.S. clinicians have been substantial: impeded insurance reimbursement, reduced research funding, gaps in clinical training, and the ongoing challenge of documenting presentations accurately within available coding options. Most U.S. clinicians document CSBD presentations under Impulse-Control Disorder Not Otherwise Specified (F63.89) — an unsatisfying solution to a real administrative problem.
The DSM-5 exclusion of Hypersexual Disorder should be distinguished from scientific rejection of CSBD as a clinical entity. The APA working group found the evidence base insufficient for formal inclusion — not that the condition was nonexistent. This distinction matters in clinical communication with patients, insurers, and colleagues. The proposed Hypersexual Disorder criteria — particularly the mood-regulation use criterion and the explicit exclusion of addiction-model dependence features — anticipated ICD-11’s eventual framing more closely than either the addiction model or earlier DSM-III-R language. Kafka’s 2010 proposal should be read as the conceptual bridge between the addiction-model era and ICD-11 recognition. U.S. clinicians documenting CSBD under F63.89 should accompany the code with clinical narrative that accurately characterizes the behavioral presentation. Insurance and audit contexts increasingly accept detailed clinical narrative as an adjunct to imprecise codes. Adequate documentation protects both patients and clinicians.